Summary
A study has been carried out investigating four different marketed oral preparations of glibenclamide, correlating the effectiveness of the drug in these preparations in lowering plasma glucose concentrations with (i) the in vitro dissolution of the drug, measured by the British Pharmacopoeal and Desaga methods, and (ii) the in vivo bioavailability, assessed in 12 healthy human volunteers.
The two dissolution methods yielded different rank orders of ease of dissolution of the drug from the various preparations; the findings of neither dissolution method correlated adequately with the results of the in vivo bioavailability studies, which correctly predicted the abilities of the preparations to reduce plasma glucose concentrations.
Relative to an oral glibenclamide solution the bioavailabilities of the drug from three tablet preparations were 0.69, 0.49 and 0.24. The mean elimination half-life of the drug was 1.5 h and assuming complete bioavailability of the drug from oral solution the mean systemic clearance was 0.095 l kg−1h−1, and the mean apparent volume of distribution was 0.20 l kg−1.
It is concluded that it may be unsafe to use in vitro dissolution data as a basis for assessing the bioequivalences of different glibenclamide preparations intended for oral use.
Similar content being viewed by others
References
Balant L, Fabre J, Zahnd GR (1975) Comparison of the pharmacokinetics of glipizide and glibenclamide in man. Eur J Clin Pharmacol 8: 63–69
Christ OE, Heptner W, Rupp W (1969) Investigations on absorption, excretion and metabolism in man after administration of14C-labelled HB 419. Horm Metab Res [Suppl ad.] 1: 51–54
Fucrella LM, Tamassia V, Valzelli G (1973) Metabolism and kinetics of the hypoglycaemic agent glipizide in man — comparison with glibenclamide. J Clin Pharmacol 13: 68–75
Sartor G, Melander A, Schersten B, Wahlin-Boll E (1980) Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. Diabetologia 18: 17–22
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chalk, J.B., Patterson, M., Smith, M.T. et al. Correlations between in vitro dissolution, in vivo bioavailability and hypoglycaemic effect of oral glibenclamide. Eur J Clin Pharmacol 31, 177–182 (1986). https://doi.org/10.1007/BF00606655
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00606655